Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report)’s share price reached a new 52-week low during trading on Tuesday after Needham & Company LLC lowered their price target on the stock from $19.00 to $14.00. Needham & Company LLC currently has a buy ratin…
Vir Biotechnology (NASDAQ:VIR) Hits New 1-Year Low After Analyst Downgrade
